F-1 EX-FILING FEES 0001611747 N/A N/A 0001611747 1 2025-09-21 2025-09-21 0001611747 2025-09-21 2025-09-21 iso4217:USD xbrli:pure xbrli:shares

Ex-Filing Fees

CALCULATION OF FILING FEE TABLES

F-1

Scinai Immunotherapeutics Ltd.

Table 1: Newly Registered and Carry Forward Securities

                                           
Line Item Type   Security Type   Security Class Title   Notes   Fee Calculation
Rule		   Amount Registered   Proposed Maximum Offering
Price Per Unit		   Maximum Aggregate Offering Price   Fee Rate   Amount of Registration Fee
                                           
Newly Registered Securities
Fees to be Paid   Equity   Ordinary shares, no par value, represented by American Depositary Share   (1)   Other   19,200,000,000   $ 0.0004   $ 7,680,000.00   0.0001531   $ 1,175.81
                                           
Total Offering Amounts:   $ 7,680,000.00         1,175.81
Total Fees Previously Paid:               0.00
Total Fee Offsets:               0.00
Net Fee Due:             $ 1,175.81

__________________________________________
Offering Note(s)

(1) Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the ordinary shares, no par value (“Ordinary Shares”), and American Depositary Shares (“ADSs”) offered hereby also include an indeterminate number of additional Ordinary Shares and ADSs as may from time to time become issuable by reason of stock splits, stock dividends, recapitalizations or other transactions.

ADSs evidenced by American Depositary Receipts issuable upon deposit of the Ordinary Shares registered hereby have been registered pursuant to a separate registration statement on Form F-6 (File No. 333-203333). Each American Depositary Share represents four thousand (4,000) Ordinary Shares.

Represents Ordinary Shares represented by ADSs registered for resale by the selling shareholder described in this Registration Statement on Form F-1. The Registrant will not receive any proceeds from the sale of its ordinary shares by the selling shareholder.

Estimated solely for the purpose of computing the amount of the registration fee for the ADSs being registered in accordance with Rule 457(c) under the Securities Act based upon a proposed maximum aggregate offering price of $1.565 per ADS (equivalent to $0.00039125 per ordinary share), the average of the high and low prices of the ADSs of the Registrant as reported on The Nasdaq Global Market on September 19, 2025, which date is within five business days of the filing of this Registration Statement on Form F-1.